BLOG

cell gene

Tessera Therapeutics Advances In Vivo Gene Therapy For SCD

Last year, Tessera Therapeutics’ CEO, Dr. Michael Severino, was my guest on Cell & Gene: The Podcast to discuss Gene Writing, the biotech’s genome